scispace - formally typeset
T

Thomas C. Chalmers

Researcher at Harvard University

Publications -  166
Citations -  23583

Thomas C. Chalmers is an academic researcher from Harvard University. The author has contributed to research in topics: Randomized controlled trial & Clinical trial. The author has an hindex of 62, co-authored 166 publications receiving 23091 citations. Previous affiliations of Thomas C. Chalmers include City University of New York & Icahn School of Medicine at Mount Sinai.

Papers
More filters
Journal ArticleDOI

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

TL;DR: Concern for the probability of missing an important therapeutic improvement because of small sample sizes deserves more attention in the planning of clinical trials.
Journal ArticleDOI

A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction.

TL;DR: Finding and analyzing all therapeutic trials in a given field has become such a difficult and specialized task that the clinical experts called on to summarize the evidence in a timely fashion need access to better databases and new statistical techniques to assist them.
Journal ArticleDOI

Meta-analyses of randomized controlled trials.

TL;DR: It is concluded that an urgent need exists for improved methods in literature searching, quality evaluation of trials, and synthesizing of the results.
Journal ArticleDOI

Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction

TL;DR: Cumulative meta-analysis of therapeutic trials facilitates the determination of clinical efficacy and harm and may be helpful in tracking trials, planning future trials, and making clinical recommendations for therapy.